<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2410222783
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2017
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        BISOLOL 2.5 mg Tablet
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        BISOPROLOL FUMARATE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        2.5
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        30
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        10.8
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="CHANELLE MEDICAL" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            CHANELLE MEDICAL
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 1916]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            AJA PHARMACEUTICAL INDUSTRIES
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            AJA PHARMACEUTICAL INDUSTRIES
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        C07AB07
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p style="text-align:justify">Bisoprolol Fumarate belongs to a group of drugs called beta-blockers. Bisoprolol Fumarate is used in combination with other medicines to treat stable chronic moderate to severe heart failure.</p><p style="text-align:justify">Bisoprolol Fumarate Tablets may be used to treat the following conditions:<br />&bull; Treatment of high blood pressure (hypertension)<br />&bull; Treatment of coronary heart disease (angina pectoris)<br />&bull; Treatment of stable chronic moderate to severe heart failure with reduced systolic ventricular function (ejection fraction 35%, based on echocardiography) in addition to ACE inhibitors, and diuretics, and optionally cardiac glycosides (for additional information see section5.1).</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p style="text-align:justify"><strong>Do not take Bisoprolol Fumarate Tablets</strong>:<br />&bull; If you are taking a MAO (monoamine oxidase) &ndash; A inhibitor, a calcium antagonist or clonidine<br />&bull; if you are allergic (hypersensitive) to bisoprolol fumarate or any of the other ingredients of Bisoprolol Fumarate tablets.<br />&bull; if you have heart failure that suddenly becomes worse and / or that may require hospital treatment<br />&bull; if you have had cardiac shock<br />&bull; if you suffer from heart block<br />&bull; if you suffer from very slow heartbeats (less than 60/minute)or sick sinus syndrome<br />&bull; if you have very poor circulation or severe Raynaud&rsquo;sSyndrome<br />&bull; if you have extremely low blood pressure<br />&bull; if you have untreated high blood pressure due to a tumour near the kidney (phaeochromocytoma)<br />&bull; have excess acid in the blood, a condition known as metabolicacidosis<br />&bull; if you suffer from acute bronchial asthma or have severebreathing difficulties.</p><p style="text-align:justify"><u>Take special care with Bisoprolol Fumarate Tablets and talk to your doctor:</u><br />&bull; if you have chest pain at rest or Prinzmetal&rsquo;s angina<br />&bull; if you have asthma or any other lung disease.<br />&bull; if you have diabetes mellitus<br />&bull; if you have psoriasis<br />&bull; if you have poor circulation<br />&bull; if you have kidney or liver disease<br />&bull; if you have an irregular heartbeat<br />&bull; if you have an overactive thyroid<br />&bull; if you are having desensitisation treatment for allergies<br />&bull; if you are pregnant, planning to become pregnant orbreast-feeding</p><p style="text-align:justify">&bull; if you are taking any other medicine &ndash; even those not prescribed to you by your doctor. Examples of these are drugs used to treat heart disease, high blood pressure, irregular heart beat, epilepsy, depression, antimalarials or rifampicin (an antibiotic)<br />&bull; if you are fasting<br />&bull; if you have phaeochromocytoma (rare tumour), bisoprolol must not be started until after treatment with another medicine (alpha-receptor blocker)<br />&bull; if you are going to be given a general anaesthetic during an operation &ndash; tell your doctor that you are taking bisoprolol</p><p style="text-align:justify"><strong>Taking other medicines:</strong><br />Medicines that you should avoid using with Bisoprolol Fumarate, unless your doctor advises otherwise:<br />&bull; Medicines called clonidine, methyldopa, moxonodine, rilmenidine, or medicines such as verapamil or diltiazem may cause your heart to beat too slowly and /orweakly.<br />&bull; Medicines for the treatment of an irregular heartbeat, such as quinidine, disopyramide, lidocaine, phenytoin, flecainide, propafenone may weaken yourheartbeat.</p><p style="text-align:justify">Medicines that should be given with Bisoprolol Fumarate, only under medical supervision:<br />&bull; other medicines used to treat hypertension such as felodipine and amlodipine may give rise to an excessive drop in blood pressure and / or heart rate.<br />&bull; other medicines for the treatment of an irregular heartbeat such as amiodarone.<br />&bull; topical beta-blockers (e.g. eye drops for glaucomatreatment)<br />&bull; medicines that affect the nervous system such as donepezil or tacrine which in combination with bisoprolol fumerate can slow the heart rate<br />&bull; oral antidiabetic medicines such as insulin can mask symptoms of low blood sugar in diabetics.<br />&bull; anaesthetics may cause an abnormal drop in blood pressure.<br />&bull; medicines known as NSAIDs (non-steroidal anti-inflammatory medicines) used to treat pain or inflammation, may decrease the blood pressure-lowering effect ofBisoprolol.<br />&bull; medicines such as isoprenaline and dobutamine may reduce their effectiveness when combined with Bisoprolol<br />&bull; medicines such as barbiturates (a type of sedative), some antidepressants (known as tricyclic antidepressants, e.g. impramine) and phenothiazines (used for mental disorders) may add to the blood pressure lowering effect of Bisoprolol Fumarate.<br />&bull; certain medicines to treat clinical shock (e. g. adrenaline, dobutamine, noradrenaline)<br />&bull; mefloquine, a medicine formalaria<br />&bull; so called monoamine oxidase inhibitors i.e. MAO-inhibitors (except MAO-B inhibitors) such as moclobemide or phenelzine (for depression).<br />Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.</p><p style="text-align:justify"><strong>Taking Bisoprolol Fumarate Tablets with food and drink</strong><br />Bisoprolol Fumarate Tablets should be taken in the morning, before, with or after breakfast. They should be swallowed whole with liquid and should not be chewed or crushed.<br />Avoid drinking excessive alcohol, since it may increase the blood pressure-lowering effect of Bisoprolol. Avoid drinking alcohol altogether, if it makes you more dizzy or more light-headed than usual.</p><p style="text-align:justify"><strong>Pregnancy and breast-feeding:</strong><br />You should not take Bisoprolol Fumarate Tablets if you are pregnant or breast-feeding. Please ask your doctor or pharmacist for advice before taking any medicine.</p><p style="text-align:justify"><strong>Driving and using machines:</strong><br />Bisoprolol Fumarate Tablets may cause side effects that may affect a person&#39;s ability to drive and use machinery particularly during the first few weeks of your treatment. You may find that your reactions are impaired, especially if you have also consumed alcohol. Examples of side effects include visual disturbances, drowsiness or dizziness. If you suffer from any of these side effects it is advisable to refrain from driving or using machinery.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p style="text-align:justify">Always take Bisoprolol Fumarate tablets exactly as your doctor has told you. You should check with your doctor or your pharmacist if you are not sure. Always take Bisoprolol Fumarate tablets in the morning, before, with, or after breakfast. Swallow the tablet/s whole with some water and do not chew or crush them.</p><p style="text-align:justify"><strong>Children:</strong> Bisoprolol Fumarate Tablet/s is/are not recommended for use in children</p><p style="text-align:justify"><strong>Adults and the elderly:</strong> When you first start taking Bisoprolol Fumarate your doctor will increase the strength of the tablets you take very gradually, until you receive the dose that suits you.</p><p style="text-align:justify">The recommended dose for the treatment of stable chronic heart failure is 10 mg once daily. This may be reduced by your doctor gradually depending on your response to treatment.</p><p style="text-align:justify"><strong>Kidney or liver insufficiency: </strong>The dosage should be increased very gradually and cautiously in patients with severe kidney or liver disorder</p><p style="text-align:justify"><strong>If you take more Bisoprolol Fumarate Tablets than you should:</strong><br />Contact your doctor or local emergency ward immediately. Take this leaflet and any tablets you still have with you. You may feel dizzy or extremely tired or notice tinnitus (ringing in you ears).</p><p style="text-align:justify"><strong>If you forget to take Bisoprolol Fumarate Tablets:</strong><br />If you forget to take a dose, take it as soon as you remember it unless it is nearly time for your next dose. Do not take a double dose to make up for a forgotten dose.</p><p style="text-align:justify"><strong>If you stop taking Bisoprolol Fumarate Tablets:</strong><br />Do not stop treatment suddenly or change the recommended dose without talking to your doctor first. If you need to stop treatment, it must be done gradually, to avoid side effects.</p><p style="text-align:justify">If you have any further questions on the use of this product, ask you doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p style="text-align:justify">Like all medicines, Bisoprolol Fumarate Tablets can cause side effects, although not everybody gets them.</p><p style="text-align:justify">The following side effects have been reported:<br /><strong>Very common (seen in more than 1 in 10 patients):</strong> slow heartbeat (in patients with chronic heart failure)</p><p style="text-align:justify"><strong>Common side effects (seen in more than 1 in 100 patients but less than 1 in 10 patients)</strong> include: upset stomach, vomiting, diarrhoea or constipation and coldness or numbness of the fingers or toes. Low blood pressure, worsening of pre-existing heart failure and weakness (asthenia). Headaches, tiredness, exhaustion, dizziness or fatigue are common side effects during the first two weeks of treatment.</p><p style="text-align:justify"><strong>Uncommon side effects (seen in more than 1 in 1,000 patients but less than 1 in 100 patients) include</strong>: interference with the normal heart rate, difficulty in breathing, breathlessness or fainting &ndash; tell your doctor as soon as possible if you notice any of these symptoms. Other uncommon side effects are low blood pressure in upright position (orthostatic hypotension), muscle weakness, cramps, difficulty in sleeping and depression.</p><p style="text-align:justify"><strong>Rare side effects (seen in more than 1 in 10,000 patients but less than 1 in 1,000) include:</strong> nightmares, hallucinations, syncope (loss of consciousness) hepatitis (inflammation of the liver) where you may notice a yellowing of the skin or the whites of your eyes, increased liver enzymes, increased blood levels of some fats, impotence, hearing impairment, dry eyes, skin reactions (rash, itching) or flushing, allergic rhinitis (blocked, runny, itchy nose).</p><p style="text-align:justify"><strong>Very rare side effects (seen in less than 1 in 10,000) include: </strong>conjunctivitis (eye inflammation), alopecia (hair loss), psoriasis like rash.</p><p style="text-align:justify">If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p style="text-align:justify">Store below 30&deg;</p><p style="text-align:justify">Do not use Bisoprolol Fumarate Tablets after the expiry date which is stated on the blister and the carton. The expiry date refers to the last day of that month. This medicinal product does not require any special storage conditions.</p><p style="text-align:justify">Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p style="text-align:justify">The active substance is bisoprolol fumarate<br />Each 2.5 mg tablet contains 2.5 mg bisoprolol fumarate.<br />Each 5 mg tablet contains 5 mg bisoprolol fumarate.<br />Each 10 mg tablet contains 10 mg bisoprolol fumarate.</p><p style="text-align:justify">The other ingredients are microcrystalline cellulose, silica, colloidal anhydrous, croscarmellose sodium, sodium starch glycolate (type A) and magnesium stearate.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Bisoprolol Fumarate 2.5 mg tablets are white to off white round biconvex tablets with a break line on one side.
Bisoprolol Fumarate 5 mg tablets are white to off white round biconvex tablets with a break line on one side.
Bisoprolol Fumarate 10 mg tablets are white to off white round biconvex tablets with a break line on one side.
They come in packs of 30 tablets (not all pack sizes may be marketed).
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Marketing Authorisation Holder&nbsp;</strong><br />AJA Pharmaceutical Industries Company, Ltd.<br />Saudi Chemical Co. Bldg. Al-Ahsa St. Malaz District<br />P.O. BOX 2665<br />Riyadh 11461<br />Saudi Arabia<br />Tel: +966 11 2066351<br />Fax: +966 11 2066349</p><p><strong>Manufacturer</strong><br />Chanelle Medical, Loughrea, Co. Galway, Ireland.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet was last approved in: October/2016
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL" style="text-align:justify">ينتمي عقار بيسولول إلى مجموعة من الأدوية تسمى معطلات موجات بيتا.</p><p dir="RTL" style="text-align:justify">يستعمل عقار بيسولول جنبا إلى جنب مع أدوية أخرى لعلاج فشل القلب المزمن من الدرجة المتوسطة إلى الشديدة.</p><p dir="RTL" style="text-align:justify">ويمكن أن تستعمل أقراص بيسولول لعلاج الحالات التالية:</p><ul><li dir="RTL" style="text-align:justify">علاج ارتفاع ضغط الدم (ضغط الدم المرتفع).</li><li dir="RTL" style="text-align:justify">علاج أمراض القلب التاجية (الذبحة الصدرية).</li><li dir="RTL" style="text-align:justify">فشل القلب المزمن من الدرجة المتوسطة إلى الشديدة. ويستعمل لعلاج هذه الحالة مع أدوية أخرى (مثل مثبطات اي سي إي، ومدرات البول وجليكوسيدات القلب).</li></ul>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="text-align:justify"><strong>يجب أن لا تتناول &nbsp;بيسولول في الحالات التالية:</strong></p><p dir="RTL" style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تستعمل أي أدوية مثبطة لأنزيم مونامين أكسيديز (MAO)، او أي من مضادات الكالسيوم أو كلونيدين.</p><p dir="RTL" style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من حساسية (فرط الحساسية) ضد بيسوبرولول فيومريت أو أي من المكونات الأخرى لأقراص بيسولول.</p><p dir="RTL" style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من فشل القلب وحدث تفاقم للمرض بصورة مفاجئة و/أو ان حالتك تتطلب العلاج في المستشفى.</p><p dir="RTL" style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا تعرضت لصدمة قلبية.</p><p dir="RTL" style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا تعرضت لحجز قلبي.</p><p dir="RTL" style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من بطء في نبض القلب (أقل من 60/دقيقة) أو من متلازمة الجيب المريض</p><p dir="RTL" style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كانت دورتك الدموية ضعيفة جدا أو كنت تعاني من متلازمة &quot;ريناود&quot;.</p><p dir="RTL" style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من انخفاض شديد في ضغط الدم.</p><p dir="RTL" style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من ارتفاع في ضغط الدم غير معالج بسبب ورم بجوار الكلية (ورم الخلايا الصبغية الباهتة).</p><p dir="RTL" style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كانت نسبة الحموضة في دمك مرتفعة وهي حالة تعرف باعتلال التحمض الأيضي.</p><p dir="RTL" style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من مرض الربو الشعبي الحاد أو صعوبة شديدة في التنفس.</p><p dir="RTL" style="text-align:justify"><strong>يجب توخي الحذر والتحدث إلى طبيبك قبل عند تناول بيسولول في الحالات التالية:</strong></p><p dir="RTL" style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من ألم بالصدر في وضعية الراحة او ما يعرف بذبحة &quot;برنزميتال&quot; الصدرية.</p><p dir="RTL" style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت مصابا بمرض الربو أو أي مرض رئوي.</p><p dir="RTL" style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت مصابا بمرض السكري.</p><p dir="RTL" style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت مصابا بمرض الصدفية.</p><p dir="RTL" style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من ضعف الدورة الدموية.</p><p dir="RTL" style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت مصابا بمرض في الكلى أو الكبد.</p><p dir="RTL" style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من عدم انتظام دقات القلب.</p><p dir="RTL" style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من فرط نشاط الغدة الدرقية.</p><p dir="RTL" style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تخضع لعلاجات مضادة للحساسية.</p><p dir="RTL" style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; بالنسبة للمرأة إذا كانت حاملاً او تنوي او تتوقع حدوث الحمل او كانت ترضع الطفل.</p><p dir="RTL" style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تستعمل أي أدوية أخرى حتى تلك التي لم يصفها لك الطبيب. ومن أمثلتها تلك الأدوية التي تستعمل لمعالجة امراض القلب او ارتفاع ضغط الدم او عدم انتظام النبض أو الصرع أو الاكتئاب أو مضادات الملارياغ او علاج ريفامبيسين (مضاد حيوي)</p><p dir="RTL" style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مرض شديد بالكبد، مرض السكري (قد تحتاج إلى ضبط للعلاجات المضادة أو ضمان جرعة&nbsp; بيسولول).</p><p dir="RTL" style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت صائما.</p><p dir="RTL" style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت مصابا بورم جوار الكلية (ورم الخلايا الصبغية الباهتة) وهو نوع نادر من الأورام، فيجب عدم البدء في استعمال بايسوبرولول حتى إكمال العلاج بدوء آخر (معطل مستقبلات الفا).</p><p dir="RTL" style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت ستعطى التخدير العام لإجراء عملية فيجب إبلاغ طبيبك انك تستعمل علاج بايسبرولول</p><p dir="RTL" style="text-align:justify"><strong>استعمال أدوية أخرى:</strong></p><p dir="RTL" style="text-align:justify">الأدوية التي يجب ان تتجنب استعمالها مع بيسولول إلا إذا نصح الطبيب بخلاف ذلك:</p><p dir="RTL" style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية المسماة كلونيدين، ميثيل دوبا، مونوكسودين، ريلميندين، أو ادوية اخرى مثل فيرابارميل او دلتازيم يمكن أن تسبب إبطاء و/أو إضعاف النبض.</p><p dir="RTL" style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية التي تستخدم لعلاج عدم انتظام النبض مثل كينيدين، دايسوبراميد، ليديوكاين، فينيتوين، فليكاينيد، بروبافينون يمكن أن تسبب إضعاف النبض.</p><p dir="RTL" style="text-align:justify">الأدوية التي يجب عدم استعمالها مع بيسولول إلا تحت إشراف الطبيب:</p><p dir="RTL" style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أدوية أخرى تستخدم لعلاج ارتفاع ضغط الدم مثل فيلوديبين وأملوديبين يمكن أن تؤدي إلى انخفاض شديد في ضغط الدم و/أو سرعة النبض.</p><p dir="RTL" style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أدوية أخرى تستخدم لعلاج عدم انتظام النبض مثل اميودارون.</p><p dir="RTL" style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مثبطات بيتا الموضعية (مثل قطرات العيونالمستخدمة لعلاج الجلوكوما)</p><p dir="RTL" style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية التي تؤثر على الجهاز العصبي مثل دونيبيزيل أو تاكرين والتي عند استخدامها مع بيسولول يمكن ان تسبب إبطاء النبض.</p><p dir="RTL" style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أدوية علاج مرض السكري التي تؤخذ بالفم مثل الأنسولين يمكن أن تحجب أعراض انخفاض سكر الدم لدى مرضى السكري.</p><p dir="RTL" style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أدوية التخدير يمكن أن تؤدي إلى انخفاض في ضغط الدم.</p><p dir="RTL" style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية التي تعرف بمضادات الإلتهاب غير الستيرويدية والتي تستعمل لعلاج الألم أو الإلتهابات يمكن أن تؤدي إلى تقليل مفعول بايسوبرولول الخافض لضغط الدم.</p><p dir="RTL" style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; بعض الأدوية مثل اتلباربتيورات (عقار منوم) وبعض مضادات الإكتئاب (المعروفة بمضادات الإكتئاب ثلاثية الحلقة مثل امبرامين)، وفينوثيازين (المستعمل لعلاج بعض الأمراض العقلية) يمكن أن تؤدي إلى زيادة مفعول بايسوبرولول الخافض لضغط الدم.</p><p dir="RTL" style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; بعض الأدوية التي تستعمل لعلاج الصدمات العامة (مثل أدرينالين، دبيوتامين، نورأدرينالين).</p><p dir="RTL" style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مفلوكين دواء لعلاج الملاريا.</p><p dir="RTL" style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مجموعة الأدوية المعروفة بمثبطات انزيم مونو-امين-اكسيديز أي مثبطات MAO (ما عدا مثبطات MAO-B).</p><p dir="RTL" style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يرجى إبلاغ طبيبك او الصيدلي إذا كنت تستعمل او استعملت حديثا أي أدوية أخرى بما فيها تلك التي يمكن الحصول عليها بدون وصفة طبية.</p><p dir="RTL" style="text-align:justify"><strong>تناول أقراص بيسولول مع الطعام والشراب:</strong></p><p dir="RTL" style="text-align:justify">يجب تناول أقراص بيسولول في الصباح قبل أو مع أو بعد الإفطار. ويجب ابتلاع القرص كاملا مع اي نوع من السوائل وعدم مضغ القرص او سحقه.</p><p dir="RTL" style="text-align:justify">تجنب شرب كميات زائدة من الكحول حيث ان ذلك يؤدي إلى زيادة مفعول بايسوبرولول الخافض لضغط الدم. ويجب ان تتجنب شرب الكحول اطلاقا إذا تبين أنه قد سبب لك الدوار او الطيش زيادة عن المعتاد.</p><p style="text-align:justify"><strong>الحمل والإرضاع:</strong></p><p dir="RTL" style="text-align:justify">المرأة الحامل أو المرضع يجب أن لا تستعمل أقراص بيسولول ويجب استشارة الطبيب أو الصيدلي قبل استعمال أي دواء.</p><p style="text-align:justify"><strong>قيادة المركبات وتشغيل الآليات:</strong></p><p dir="RTL" style="text-align:justify">&nbsp;أقراص بيسولول قد تسبب بعض الأعراض الجانبية التي يمكن أن تؤثر في قدرة الشخص على قيادة المركبات وتشغيل الآليات وذلك خلال الأسابيع القليلة الأولى من العلاج.</p><p dir="RTL" style="text-align:justify">وقد تلاحظ حدوث قصور في ردود أفعالك وخاصة إذا تعاطيت الكحول مع هذا الدواء.</p><p dir="RTL" style="text-align:justify">بعض من أمثلة التأثيرات الجانبية تشمل اضطرابات في النظر، النعاس او الدوار. فإذا حدث لك أي من تلك التأثيرات الجانبية فمن الأفضل ان تمتنع عن قيادة المركبات أو تشغيل الآليات.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="text-align:justify">يجب تناول الأقراص دائما بالطريقة التي يصفها لك الطبيب. وإذا لم تكن متأكداً استشر طبيبك أو الصيدلي. ويجب ان تأخذ أقراص بيسولول في الصباح قبل أو مع أو بعد الإفطار، ويجب ابتلاع القرص كاملا مع اي نوع من السوائل وعدم مضغ القرص او سحقه.</p><p dir="RTL" style="text-align:justify"><strong>الأطفال:</strong></p><p dir="RTL" style="text-align:justify">لا ينصح بإعطاء أقراص بيسولول للأطفال</p><p dir="RTL" style="text-align:justify"><strong>البالغون وكبار السن:</strong></p><p dir="RTL" style="text-align:justify">عند استعمال أقراص بيسولول للمرة الأولى سيقوم الطبيب بزيادة الجرعة تدريجيا وبعناية شديدة حتى تصل إلى الجرعة التي تناسبك.</p><p dir="RTL" style="text-align:justify">الجرعة الموصى بها لعلاج فشل القلب المزمن المستقر هي 10ملغم مرة واحدة يوميا. ويمكن تخفيض تلك الجرعة من قبل الطبيب تدريجيا بحسب استجابتك للعلاج.</p><p dir="RTL" style="text-align:justify"><strong>قصور الكلى او الكبد:</strong></p><p dir="RTL" style="text-align:justify">يجب زيادة الجرعة تدريجيا وبحذر شديد بالنسبة للمرضى الذين يعانون من قصور الكلى او الكبد</p><p dir="RTL" style="text-align:justify"><strong>إذا تناولت جرعة زائدة أكثر مما يجب من أقراص بيسولول:</strong></p><p dir="RTL" style="text-align:justify">في مثل تلك الحالة يجب مراجعة الطبيب او قسم الطوارئ في أقرب مركز طبي فوراً. ويجب ان تأخذ معك هذه النشرة وأي أقراص متبقية من هذا الدواء. وقد تشعر بالدوار او التعب الشديد أو تشعر بطنين في الأذنين.</p><p dir="RTL" style="text-align:justify"><strong>إذا نسيت ان تتناول أقراص بيسولول:</strong></p><p dir="RTL" style="text-align:justify">إذا نسيت ان تأخذ جرعة فيجب ان تأخذها في اقرب فرصة عند تذكرهاإلا إذا كان الوقت قد اقترب أو حان لأخذ الجرعة التالية. لأا تضاعف الجرعة كي تعوض الجرعة التي فاتتك.</p><p dir="RTL" style="text-align:justify"><strong>إذا توقفت عن تناول أقراص بيسولول:</strong></p><p style="text-align:justify">لا تتوقف عن اخذ العلاج فجأة او تغير الجرعة الموصى بها دون استشارة الطبيب أولا. وإذا كنت بحاجة إلى وقف العلاج فيجب ان يتم ذلك تدريجيا لتجنب حدوث التأثيرات الجانبية.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="text-align:justify">أقراص بيسولول كغيرها من الأدوية يمكن أن تسبب آثاراً جانبية مع انها لا تظهر عند كل شخص يستعملها.</p><p dir="RTL" style="text-align:justify">وقد تم الإبلاغ عن التأثيرات الجانبية التالية:</p><p dir="RTL" style="text-align:justify"><strong><u>تأثيرات جانبية شائعة جداً</u></strong> (تحدث لدى 1 من بين كل 10 مرضى): بطء النبض (لدى المرضى المصابين بفشل القلب المزمن)</p><p dir="RTL" style="text-align:justify"><strong><u>تأثيرات جانبية شائعة</u></strong> (تحدث لدى 1 من بين كل 100 مريض ولكن اقل من 1 بين كل 10 مرضى): تشمل هذه التأثيرات ما يلي:اضطرابات بالمعدة (غثيان)، تقيؤ، إسهال، أو إمساك، برودة أو خدر في اصابع اليدين أو اصابع القدمين. انخفاض ضغط الدم، تفاقم فشل القلب الموجود أصلامع ضعف (وهن).</p><p dir="RTL" style="text-align:justify">الصداع، أو التعب، أو الإعياء ، أو الدوار ، أو الإجهاد هي تأثيرات جانبية شائعة خلال الأسبوعين الأولين من بدء العلاج.</p><p dir="RTL" style="text-align:justify"><strong><u>تأثيرات جانبية غير شائعة</u></strong> (تحدث لدى اكثر من 1 من بين كل 1000 مريض ولكن أقل من 1 من بين كل 100 مريض) وتشمل ما يلي: خلل في معدل النبض الطبيعي، صعوبة في التنفس، انقطاع النفس أو الإغماء المؤقت؛ يجب أن تخبر طبيبك حالما تلاحظ أي من الأعراض المذكورة.</p><p dir="RTL" style="text-align:justify">ومن الآثار الجانبية غير الشائعة أيضا انخفاض ضغط الدم في وضعية الوقوف (انخفاض الضغط افي الوضع القائم)، ضعف بالعضلات ، تقلصات عضلية، صعوبة النوم، الاكتئاب.</p><p dir="RTL" style="text-align:justify"><strong><u>تأثيرات جانبية نادرة</u> </strong>(تحدث لدى اكثر من 1 من بين كل 10,000 مريض ولكن أقل من 1 من بين كل 1000 مريض) وتشمل ما يلي: احلام مزعجة (كوابيس) هلوسة، إغماء، التهاب الكبد (ومن اعراضه تغير لون الجلد وبياض العينين الى الأصفر) ارتفاع في مستويات أنزيمات الكبد، ارتفاع مستويات بعض انواع الدهون في الدم، الضعف الجنسي، قصور في السمع، جفاف العينين، ردود فعل جلدية، (طفح جلدي، حكة) أو احمرار الجلد، التهاب الأنف التحسسي (انسداد الأنف او الرشح او الحكة بالأنف)</p><p dir="RTL" style="text-align:justify"><strong><u>تأثيرات جانبية نادرة جدا</u> </strong>(تحدث لدى أقل من 1 من بين كل 10,000 مريض) وتشمل: التهاب ملتحمة العين ، الصلع (تساقط الشعر) طفح جلدي يشبه الصدفية.</p><p style="text-align:justify">إذا شعرت بأن أياً من الأعراض المذكورة قد تفاقم لدرجة خطيرة أو لاحظت أي آثار جانبية اخرى لم تذكر في هذه النشرة فيجب عليك أن تبلغ الطبيب او الصيدلي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="text-align:justify">يحفظ في درجة حرارة اقل من 30 درجة مئوية.</p><p dir="RTL" style="text-align:justify">لا تستعمل الدواء بعد تاريخ انتهاء الصلاحية المطبوع على العبوة أو العلبة. ويشير تاريخ انتهاء الصلاحية إلى آخر يوم في ذلك الشهر.</p><p dir="RTL" style="text-align:justify">وعند التخلص من الدواء المنتهي فيجب عدم إلقائه في القمامة المنزلية أو مع مياه الصرف. ويجب الاستفسار من الصيدلي حول كيفية التخلص بطريقة سليمة من الأدوية التي لم يعد لها احتياج. وهذه الإجراءات تساعد في حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="text-align:justify">كل قرص 2.5 ملغم يحتوي على 2.5 ملغم من مادة بيسوبرولول فيومريت.</p><p dir="RTL" style="text-align:justify">كل قرص 5 ملغم يحتوي على 5 ملغم من مادة بيسوبرولول فيومريت.</p><p dir="RTL" style="text-align:justify">كل قرص 10 ملغم يحتوي على 10 ملغم من مادة بيسوبرولول فيومريت.</p><p dir="RTL" style="text-align:justify">المكونات الأخرى هي: سيليولوز متبلور دقيق، سيليكا، انهايدراس غروي، كروسكارميلوز صوديوم، جليكولات نشا صوديوم نوع-اي، ستيارات الماغنيسيوم.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="text-align:justify">المادة الفعالة هي &quot;بيسوبرولول فيومريت&quot;.</p><p dir="RTL" style="text-align:justify">أقراص بيسولول 2.5 ملغم هي اقراص مستديرة محدبة من جهتين بلون أبيض ناصع او أبيض باهت مع خط تقسيم في المنتصف في احدى الجهتين.</p><p dir="RTL" style="text-align:justify">أقراص بيسولول 5 ملغم هي اقراص مستديرة محدبة من جهتين بلون أبيض ناصع او أبيض باهت مع خط تقسيم في المنتصف في احدى الجهتين.</p><p dir="RTL" style="text-align:justify">أقراص بيسولول 10 ملغم هي اقراص مستديرة محدبة من جهتين بلون أبيض ناصع او أبيض باهت مع خط تقسيم في المنتصف في احدى الجهتين.</p><p style="text-align:justify">وهي تقدم في عبوات تحتوي على 30 قرص.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>مالك حق&nbsp;التسویق</strong><br />شركة أجا للصناعات الدوائية&nbsp;المحدودة<br />ص.ب 2665<br />الرياض11461<br />المملكة العربية&nbsp;السعودية</p><p dir="RTL"><strong>صنع </strong>لصالح شركة أجا للصناعات الدوائية&nbsp;المحدودة لدى:<br />شركة تشانيل ميديكال لوجريا<br />جالوي، إيرلندا</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            تمت مراجعة هذه النشرة بتاريخ
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Bisoprolol Fumarate 2.5mg, 5mg, 10mg Tablets
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each tablet contains 2.5mg, 5mg, 10 mg of bisoprolol fumarate
For a full list of excipients, see section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Tablet
Bisoprolol Fumarate 2.5mg, 5mg, 10 mg Tablets is a white to off white round biconvex tablet with a breakline on one side.
The Tablets can be divided into equal doses
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <ul><li style="text-align: justify;">Treatment of high blood pressure (hypertension)</li><li style="text-align: justify;">Treatment of coronary heart disease (angina pectoris)</li><li style="text-align: justify;">Treatment of stable chronic moderate to severe heart failure with reduced systolic ventricular function (ejection fraction &le; 35%, based on echocardiography) in addition to ACE inhibitors, and diuretics, and optionally cardiac glycoside</li></ul>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:justify">Oral use</p><p style="text-align:justify">The patients should have stable chronic heart failure without acute failure during the past six weeks and a mainly unchanged basic therapy during the past two weeks. They should be treated at optimal dose with an ACE inhibitor (or other vasodilator in case of intolerance to ACE inhibitors) and a diuretic, and optionally cardiac glycosides, prior to the administration of bisoprolol.</p><p style="text-align:justify">It is recommended that the treating physician should be experienced in the management of chronic heart failure.</p><p style="text-align:justify">Warning: The treatment of stable chronic heart failure with bisoprolol fumarate has to be initiated with a titration phase as given in the description below.</p><p style="text-align:justify">The treatment with bisoprolol fumarate is to be started with a gradual uptitration according to the following steps:</p><p style="text-align:justify">-&nbsp; 2.5 mg once daily for a further week, if well tolerated increase to</p><p style="text-align:justify">-&nbsp; 5 mg once daily for the 4 following weeks, if well tolerated increase to</p><p style="text-align:justify">-&nbsp; 10 mg once daily for the maintenance therapy.</p><p style="text-align:justify">After initiation of treatment with 1.25 mg, the patients should be observed over a period of approximately 4 hours (especially as regards blood pressure, heart rate, conduction disturbances, signs of worsening of heart failure).</p><p style="text-align:justify">The maximum recommended dose is 10 mg once daily.</p><p style="text-align:justify">Occurrence of adverse events may prevent all patients being treated with the maximum recommended dose. If necessary, the dose reached can also be decreased step by step. The treatment may be interrupted if necessary and reintroduced as appropriate. During the titration phase, in case of worsening of the heart failure or intolerance, it is recommended first to reduce the dose of bisoprolol fumarate, or to stop immediately if necessary (in case of severe hypotension, worsening of heart failure with acute pulmonary oedema, cardiogenic shock, symptomatic bradycardia or AV block).</p><p style="text-align:justify">Treatment of stable chronic heart failure with bisoprolol fumarate is generally a long-term treatment.</p><p style="text-align:justify">The treatment with bisoprolol fumarate is not recommended to be stopped abruptly since this might lead to a transitory worsening of heart failure. If discontinuation is necessary, the dose should be gradually decreased divided into halves weekly.</p><p style="text-align:justify">Bisoprolol Fumarate Tablets should be taken in the morning and can be taken with food. They should be swallowed with liquid and should not be chewed.</p><p style="text-align:justify"><em>Renal or liver insufficiency:</em></p><p style="text-align:justify">There is no information regarding pharmacokinetics of bisoprolol fumarate in patients with chronic heart failure and with impaired liver or renal function.</p><p style="text-align:justify">Uptitration of the dose in these populations should therefore be made with additional caution.</p><p style="text-align:justify"><em>Elderly</em></p><p style="text-align:justify">No dosage adjustment is required.</p><p style="text-align:justify"><em>Children</em></p><p style="text-align:justify">There is no paediatric experience with bisoprolol, therefore its use cannot be recommended for children</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Bisoprolol Fumarate is contraindicated in chronic heart failure patients with:
-	acute heart failure or during episodes of heart failure decompensation requiring i.v. inotropic therapy
-	cardiogenic shock
-	AV block of second or third degree
-	sick sinus syndrome
-	sinoatrial block
-	symptomatic bradycardia with less than 60 beats/min before the start of therapy
-	symptomatic hypotension (systolic blood pressure less than 100 mm Hg)
-	severe bronchial asthma or severe chronic obstructive pulmonary disease
-	late stages of peripheral arterial occlusive disease and Raynaud's syndrome
-	untreated phaeochromocytoma (see 4.4)
-	metabolic acidosis
-	hypersensitivity to bisoprolol or to any of the excipients
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:justify">The treatment of stable chronic heart failure with bisoprolol has to be initiated with a special titration phase. (Please refer to section 4.2)</p><p style="text-align:justify">Especially in patients with ischaemic heart disease the cessation of therapy with bisoprolol must not be done abruptly unless clearly indicated, because</p><p style="text-align:justify">this may lead to transitional worsening of heart condition (Please refer to section 4.2)</p><p style="text-align:justify">The initiation and cessation of treatment of stable chronic heart failure with bisoprolol necessitates regular monitoring. (Please refer to section 4.2).</p><p style="text-align:justify">Bisoprolol Fumarate must be used with caution in:</p><p style="text-align:justify">-&nbsp; bronchospasm (bronchial asthma, obstructive airways diseases)</p><p style="text-align:justify">-&nbsp; diabetes mellitus with large fluctuations in blood glucose values; symptoms of hypoglycaemia can be masked</p><p style="text-align:justify">-&nbsp; strict fasting</p><p style="text-align:justify">-&nbsp; ongoing desensitisation therapy. As with other beta-blockers, bisoprolol may Increase both the sensitivity towards allergens and the severity of anaphylactic reactions. Epinephrine treatment may not always yield the expected therapeutic effect,</p><p style="text-align:justify">-&nbsp; AV block of first degree</p><p style="text-align:justify">-&nbsp; Prinzmetal&#39;s angina</p><p style="text-align:justify">-&nbsp; peripheral arterial occlusive disease (intensification of complaints might happen especially during the start of therapy)</p><p style="text-align:justify">-&nbsp; General anaesthesia</p><p style="text-align:justify">In patients undergoing general anaesthesia beta-blockade reduces the incidence of arrhythmias and myocardial ischemia during induction and intubation, and the post-operative period. It is currently recommended that maintenance beta-blockade be continued peri-operatively. The anaesthetist must be aware of beta-blockade because of the potential for interactions with other drugs, resulting in bradyarrhythmias, attenuation of the reflex tachycardia and the decreased reflex ability to compensate for blood loss. If it is thought necessary to withdraw beta-blocker therapy before surgery, this should be done gradually and completed about 48 hours before anaesthesia.</p><p style="text-align:justify">There is no therapeutic experience of bisoprolol fumarate treatment of heart failure in patients with the following diseases and conditions:</p><p style="text-align:justify">-&nbsp; NYHA class II heart failure</p><p style="text-align:justify">-&nbsp; insulin dependent diabetes mellitus (type I)</p><p style="text-align:justify">-&nbsp; impaired renal function (serum creatinine&gt;300 micromol/l)</p><p style="text-align:justify">-&nbsp; impaired liver function</p><p style="text-align:justify">-&nbsp; patients older than 80 years</p><p style="text-align:justify">-&nbsp; restrictive cardiomyopathy</p><p style="text-align:justify">-&nbsp; congenital heart disease</p><p style="text-align:justify">-&nbsp; haemodynamically significant organic valvular disease</p><p style="text-align:justify">-&nbsp; myocardial infarction within 3 months</p><p style="text-align:justify">Combination of bisoprolol fumarate with calcium antagonists of the verapamil and diltiazem type, with Class I antiarrhythmic drugs and with centrally acting antihypertensive drugs is generally not recommended, for details please refer to section 4.5.</p><p style="text-align:justify">In bronchial asthma or other chronic obstructive lung diseases, which may cause symptoms, bronchodilating therapy should be given concomitantly. Occasionally an increase of the airway resistance may occur in patients with asthma, therefore the dose of beta2-stimulants may have to be increased.</p><p style="text-align:justify">Patients with psoriasis or with a history of psoriasis should only be given betablockers (e.g. bisoprolol fumarate ) after carefully balancing the benefits against the risks.</p><p style="text-align:justify">In patients with phaeochromocytoma bisoprolol must not be administered until after alpha-receptor blockade.</p><p style="text-align:justify">Under treatment with bisoprolol fumarate the symptoms of a thyrotoxicosis may be masked</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:justify"><u>Combinations not recommended</u></p><p style="text-align:justify">Class I antiarrhythmic drugs (e.g. quinidine, disopyramide; lidocaine, phenytoin; flecainide, propafenone): Effect on atrio-ventricular conduction time may be potentiated and negative inotropic effect increased.</p><p style="text-align:justify">Calcium antagonists of the verapamil type and to a lesser extent of the diltiazem type: Negative influence on contractility and atrio-ventricular conduction. Intravenous administration of verapamil in patients on &beta;-blocker treatment may lead to profound hypotension and atrioventricular block.</p><p style="text-align:justify">Centrally-acting antihypertensive drugs: Concomitant use of centrally-acting antihypertensive drugs may lead to reduction of heart rate and cardiac output and to vasodilatation. Abrupt withdrawal may increase the risk of &#39;rebound hypertension&#39;.</p><p style="text-align:justify">Combinations to be used with caution</p><p style="text-align:justify">Calcium antagonists of the dihydropyridine type such as felodipine and amlodipine: Concomitant use may increase the risk of hypotension, and an increase in the risk of a further deterioration of the ventricular pump function in patients with heart failure cannot be excluded.</p><p style="text-align:justify">Class-III antiarrhythmic drugs (e.g. amiodarone): Effect on atrio- conduction time may be potentiated.</p><p style="text-align:justify">Topical beta-blockers (e.g. eye drops for glaucoma treatment) may add to the systemic effects of bisoprolol.</p><p style="text-align:justify">Parasympathomimetic drugs: Concomitant use may increase atrio-ventricular conduction time and the risk of bradycardia.</p><p style="text-align:justify">Insulin and oral antidiabetic drugs: Intensification of blood sugar lowering effect. Blockade of beta-adrenoreceptors may mask symptoms of hypoglycaemia.</p><p style="text-align:justify">Anaesthetic agents: Attenuation of the reflex tachycardia and increase of the risk of hypotension (for further information on general anaesthesia see also section 4.4.).</p><p style="text-align:justify">Digitalis glycosides: Reduction of heart rate, increase of atrio-ventricular conduction time.</p><p style="text-align:justify">Non-steroidal anti-inflammatory drugs (NSAIDs): NSAIDs may reduce the hypotensive effect of bisoprolol.</p><p style="text-align:justify">&beta;-Sympathomimetic agents (e.g. isoprenaline, dobutamine): Combination with bisoprolol may reduce the effect of both agents.</p><p style="text-align:justify">Sympathomimetics that activate both &beta;- and &alpha;-adrenoceptors (e.g. noradrenaline, adrenaline): Combination with bisoprolol may unmask the &alpha;- adrenoceptor-mediated vasoconstrictor effects of these agents leading to blood pressure increase and exacerbated intermittent claudication. Such interactions are considered to be more likely with nonselective &beta;-blockers.</p><p style="text-align:justify">Concomitant use with antihypertensive agents as well as with other drugs with blood pressure lowering potential (e.g. tricyclic antidepressants, barbiturates, phenothiazines) may increase the risk of hypotension.</p><p style="text-align:justify">Combinations to be considered Mefloquine: increased risk of bradycardia</p><p style="text-align:justify">Monoamine oxidase inhibitors (except MAO-B inhibitors): Enhanced hypotensive effect of the beta-blockers but also risk for hypertensive crisis.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:justify"><u>Pregnancy</u></p><p style="text-align:justify">Bisoprolol Fumarate has pharmacological effects that may cause harmful effects on pregnancy and/or the fetus/newborn. In general, beta-adrenoceptor blockers reduce placental perfusion, which has been associated with growth retardation, intrauterine death, abortion or early labour. Adverse effects (e.g. hypoglycaemia and bradycardia) may occur in the fetus and newborn infant. If treatment with beta-adrenoceptor blockers is necessary, beta<sub>1</sub>-selective adrenoceptor blockers are preferable.</p><p style="text-align:justify">Bisoprolol should not be used during pregnancy unless clearly necessary. If treatment with bisoprolol is considered necessary, the uteroplacental blood flow and the fetal growth should be monitored. In case of harmful effects on pregnancy or the fetus alternative treatment should be considered. The newborn infant must be closely monitored. Symptoms of hypoglycaemia and bradycardia are generally to be expected within the first 3 days.</p><p style="text-align:justify"><u>Breast-feeding</u></p><p style="text-align:justify">It is not known whether this drug is excreted in human milk. Therefore, breastfeeding is not recommended during administration of bisoprolol fumarate.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:justify">In a study with coronary heart disease patients bisoprolol fumarate did not impair driving performance. However, due to individual variations in reactions to the drug, the ability to drive a vehicle or to operate machinery may be impaired. This should be considered particularly at start of treatment and upon change of medication as well as in conjunction with alcohol.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:justify">Clinical trial data</p><p style="text-align:justify">The table below shows incidences of adverse events reported from both the placebo and the bisoprolol cohort of the CIBIS II trial. Regardless of causal relationship all adverse events are included. Each patient is only counted once for each adverse event occurring in at least 5% of the study population.</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p style="text-align:justify">Preferred Term</p><p style="text-align:justify">WHO</p></td><td colspan="2" style="vertical-align:top"><p style="text-align:justify">Placebo (n=1321)</p></td><td colspan="2" style="vertical-align:top"><p style="text-align:justify">Bisoprolol (n=1328)</p></td></tr><tr><td style="vertical-align:top"><p style="text-align:justify">&nbsp;</p></td><td style="vertical-align:top"><p style="text-align:justify">Pat. with</p><p style="text-align:justify">AE</p></td><td style="vertical-align:top"><p style="text-align:justify">% Pat. with</p><p style="text-align:justify">AE</p></td><td style="vertical-align:top"><p style="text-align:justify">Pat. with</p><p style="text-align:justify">AE</p></td><td style="vertical-align:top"><p style="text-align:justify">% Pat. with</p><p style="text-align:justify">AE</p></td></tr><tr><td style="vertical-align:top"><p style="text-align:justify">Cardiac failure</p></td><td style="vertical-align:top"><p style="text-align:justify">301</p></td><td style="vertical-align:top"><p style="text-align:justify">22.8</p></td><td style="vertical-align:top"><p style="text-align:justify">244</p></td><td style="vertical-align:top"><p style="text-align:justify">18.4</p></td></tr><tr><td style="vertical-align:top"><p style="text-align:justify">Dyspnoea</p></td><td style="vertical-align:top"><p style="text-align:justify">224</p></td><td style="vertical-align:top"><p style="text-align:justify">17.0</p></td><td style="vertical-align:top"><p style="text-align:justify">183</p></td><td style="vertical-align:top"><p style="text-align:justify">13.8</p></td></tr><tr><td style="vertical-align:top"><p style="text-align:justify">Dizziness</p></td><td style="vertical-align:top"><p style="text-align:justify">126</p></td><td style="vertical-align:top"><p style="text-align:justify">9.5</p></td><td style="vertical-align:top"><p style="text-align:justify">177</p></td><td style="vertical-align:top"><p style="text-align:justify">13.3</p></td></tr><tr><td style="vertical-align:top"><p style="text-align:justify">Cardiomyopathy</p></td><td style="vertical-align:top"><p style="text-align:justify">132</p></td><td style="vertical-align:top"><p style="text-align:justify">10.0</p></td><td style="vertical-align:top"><p style="text-align:justify">141</p></td><td style="vertical-align:top"><p style="text-align:justify">10.6</p></td></tr><tr><td style="vertical-align:top"><p style="text-align:justify">Bradycardia</p></td><td style="vertical-align:top"><p style="text-align:justify">60</p></td><td style="vertical-align:top"><p style="text-align:justify">4.5</p></td><td style="vertical-align:top"><p style="text-align:justify">202</p></td><td style="vertical-align:top"><p style="text-align:justify">15.2</p></td></tr><tr><td style="vertical-align:top"><p style="text-align:justify">Hypotension</p></td><td style="vertical-align:top"><p style="text-align:justify">96</p></td><td style="vertical-align:top"><p style="text-align:justify">7.3</p></td><td style="vertical-align:top"><p style="text-align:justify">152</p></td><td style="vertical-align:top"><p style="text-align:justify">11.4</p></td></tr><tr><td style="vertical-align:top"><p style="text-align:justify">Tachycardia</p></td><td style="vertical-align:top"><p style="text-align:justify">144</p></td><td style="vertical-align:top"><p style="text-align:justify">10.9</p></td><td style="vertical-align:top"><p style="text-align:justify">79</p></td><td style="vertical-align:top"><p style="text-align:justify">5.9</p></td></tr><tr><td style="vertical-align:top"><p style="text-align:justify">Fatigue</p></td><td style="vertical-align:top"><p style="text-align:justify">94</p></td><td style="vertical-align:top"><p style="text-align:justify">7.1</p></td><td style="vertical-align:top"><p style="text-align:justify">123</p></td><td style="vertical-align:top"><p style="text-align:justify">9.3</p></td></tr><tr><td style="vertical-align:top"><p style="text-align:justify">Viral infection</p></td><td style="vertical-align:top"><p style="text-align:justify">75</p></td><td style="vertical-align:top"><p style="text-align:justify">5.7</p></td><td style="vertical-align:top"><p style="text-align:justify">86</p></td><td style="vertical-align:top"><p style="text-align:justify">6.5</p></td></tr><tr><td style="vertical-align:top"><p style="text-align:justify">Pneumonia</p></td><td style="vertical-align:top"><p style="text-align:justify">69</p></td><td style="vertical-align:top"><p style="text-align:justify">5.2</p></td><td style="vertical-align:top"><p style="text-align:justify">65</p></td><td style="vertical-align:top"><p style="text-align:justify">4.9</p></td></tr></tbody></table><p style="text-align:justify">AE = Adverse Events <u>Post-marketing data</u></p><p style="text-align:justify">The following data results from post-marketing experience with bisoprolol fumarate:</p><p style="text-align:justify">Very common (&ge; 1/10); common (&ge;1% and &lt;10%), uncommon (&ge; 1/1000, &lt; 1/100); rare (&ge; 1/10000, &lt; 1/1000); very rare (&lt; 1/10000).</p><p style="text-align:justify"><u>Investigations</u></p><p style="text-align:justify">Rare: increased triglycerides, increased liver enzymes (ALAT, ASAT)</p><p style="text-align:justify"><u>Cardiac disorders:</u></p><p style="text-align:justify">Very common: bradycardia (in patients with chronic heart failure) Common: worsening of pre-existing heart failure (in patients with chronic heart failure)</p><p style="text-align:justify">Uncommon: bradycardia (in patients with hypertension or angina pectoris), AV-stimulus disturbances, worsening of pre-existing heart failure (in patients with hypertension or angina pectoris).</p><p style="text-align:justify"><u>Ear and labyrinth disorders:</u></p><p style="text-align:justify">Rare: hearing impairment.</p><p style="text-align:justify"><u>Eye disorders:</u></p><p style="text-align:justify">Rare: reduced tear flow (to be considered if the patient uses lenses). Very rare: conjunctivitis.</p><p style="text-align:justify"><u>Gastrointestinal disorders:</u></p><p style="text-align:justify">Common: gastrointestinal complaints such as nausea, vomiting, diarrhoea, constipation.</p><p style="text-align:justify"><u>General disorders:</u></p><p style="text-align:justify">Common: asthenia (patients with chronic heart failure), fatigue* Uncommon: Muscular weakness and cramps, asthenia (in patients with hypertension or angina pectoris).</p><p style="text-align:justify"><u>Hepatobiliary disorders:</u></p><p style="text-align:justify">Rare: hepatitis.</p><p style="text-align:justify"><u>Nervous system disorders:</u></p><p style="text-align:justify">Common: Tiredness*, exhaustion*, dizziness*, headache*. Uncommon: Sleep disturbances, depression.</p><p style="text-align:justify">Rare: Nightmares, hallucinations, syncope.</p><p style="text-align:justify"><u>Reproductive system and breast disorders:</u></p><p style="text-align:justify">Rare: Potency disorders.</p><p style="text-align:justify"><u>Respiratory, thoracic and mediastinal disorders:</u></p><p style="text-align:justify">Uncommon: Bronchospasm in patients with bronchial asthma or a history of obstructive airways disease.</p><p style="text-align:justify">Rare: allergic rhinitis.</p><p style="text-align:justify"><u>Skin and subcutaneous tissue disorders:</u></p><p style="text-align:justify">Rare: hypersensitivity reactions (itching, flush, rash).</p><p style="text-align:justify">Very rare: beta-blockers may provoke or worsen psoriasis or induce psoriasis-like rash, alopecia.</p><p style="text-align:justify"><u>Vascular disorders:</u></p><p style="text-align:justify">Common: Feeling of coldness or numbness in the extremities, hypotension especially in patients with heart failure.</p><p style="text-align:justify">Uncommon: orthostatic hypotension.</p><p style="text-align:justify"><u>Musculoskeletal and connective tissue disorders:</u></p><p style="text-align:justify">Uncommon: muscle weakness, muscle cramps</p><p style="text-align:justify"><u>Psychiatric disorders</u></p><p style="text-align:justify">Uncommon: depression, sleep disorders Rare: nightmares, hallucinations</p><p style="text-align:justify">*These symptoms especially occur at the beginning of the therapy. They are generally mild and usually disappear within 1-2 weeks.</p><p style="text-align:justify">To report any side effect(s):</p><ul><li style="text-align: justify;"><strong>Saudi Arabia:</strong><ul><li>The National Pharmacovigilance Centre (NPC)<ul><li>Fax: +966-11-205-7662</li><li>SFDA Call Center: 19999</li><li>E-mail: npc.drug@sfda.gov.sa</li><li>Website: https://ade.sfda.gov.sa&nbsp;</li></ul></li></ul></li><li style="text-align: justify;"><strong>Other GCC States:</strong><br />Please contact the relevant competent authority.</li></ul>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:justify">With overdose (e.g. daily dose of 15 mg instead of 7.5 mg) third degree AV- block, bradycardia, and dizziness have been reported. In general the most common signs expected with overdosage of a beta-blocker are bradycardia, hypotension, bronchospasm, acute cardiac insufficiency and hypoglycaemia. To date a few cases of overdose (maximum: 2000 mg) with bisoprolol have been reported in patients suffering from hypertension and/or coronary heart disease showing bradycardia and/or hypotension; all patients recovered.</p><p style="text-align:justify">There is a wide interindividual variation in sensitivity to one single high dose of bisoprolol and patients with heart failure are probably very sensitive.</p><p style="text-align:justify">Therefore it is mandatory to initiate the treatment of these patients with a gradual uptitration according to the scheme given in section 4.2.</p><p style="text-align:justify">If overdose occurs, bisoprolol fumarate treatment should be stopped and supportive and symptomatic treatment should be provided. Limited data suggest that bisoprolol is hardly dialysable. Based on the expected pharmacologic actions and recommendations for other beta-blockers, the following general measures should be considered when clinically warranted.</p><p style="text-align:justify">Bradycardia: Administer intravenous atropine. If the response is inadequate, isoprenaline or another agent with positive chronotropic properties may be given cautiously. Under some circumstances, transvenous pacemaker insertion may be necessary.</p><p style="text-align:justify">Hypotension: Intravenous fluids and vasopressors should be administered. Intravenous glucagon may be useful.</p><p style="text-align:justify">AV block (second or third degree): Patients should be carefully monitored and treated with isoprenaline infusion or transvenous cardiac pacemaker insertion.</p><p style="text-align:justify">Acute worsening of heart failure: Administer i.v. diuretics, inotropic agents, vasodilating agents.</p><p style="text-align:justify">Bronchospasm: Administer bronchodilator therapy such as isoprenaline, beta<sub>2</sub>-sympathomimetic drugs and/or aminophylline.</p><p style="text-align:justify">Hypoglycaemia: Administer i.v. glucose.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:justify">Pharmacotherapeutic group: Beta blocking agents, selective ATC Code: C07AB07</p><p style="text-align:justify">Bisoprolol fumarate is a highly beta<sub>1</sub>-selective-adrenoceptor blocking agent, lacking intrinsic stimulating and relevant membrane stabilising activity. It only shows low affinity to the beta<sub>2</sub>-receptor of the smooth muscles of bronchi and vessels as well as to the beta<sub>2</sub>-receptors concerned with metabolic regulation. Therefore, bisoprolol fumarate is generally not to be expected to influence the airway resistance and beta<sub>2</sub>-mediated metabolic effects. Its beta<sub>1</sub>-selectivity extends beyond the therapeutic dose range.</p><p style="text-align:justify">In total 2647 patients were included in the CIBIS II trial. 83% (n = 2202) were in NYHA class III and 17% (n = 445) were in NYHA class IV. They had stable symptomatic systolic heart failure (ejection fraction &lt;35%, based on echocardiography). Total mortality was reduced from 17.3% to 11.8% (relative reduction 34%). A decrease in sudden death (3.6% vs 6.3%, relative reduction 44%) and a reduced number of heart failure episodes requiring hospital admission (12% vs 17.6%, relative reduction 36%) was observed.</p><p style="text-align:justify">Finally, a significant improvement of the functional status according to NYHA classification has been shown. During the initiation and titration of bisoprolol hospital admission due to bradycardia (0.53%), hypotension (0.23%), and acute decompensation (4.97%) were observed, but they were not more frequent than in the placebo-group (0%, 0.3% and 6.74%). The numbers of fatal and disabling strokes during the total study period were 20 in the bisoprolol group and 15 in the placebo group.</p><p style="text-align:justify">The CIBIS III trial investigated 1010 patients aged &ge; 65 years with mild to moderate chronic heart failure (CHF; NYHA class II or III) and left ventricular ejection fraction &le;35%, who had not been treated previously with ACE inhibitors, beta-Blockers,or angiotens in receptor blockers. Patients were treated with a combination of Bisoprolol Fumarate and enalapril for 6 to 24 months after an initial 6 months treatment with either Bisoprolol Fumarate or enalapril.</p><p style="text-align:justify">There was a trend toward higher frequency of chronic heart failure worsening when Bisoprolol Fumarate was used as the initial 6 months treatment. Non</p><p style="text-align:justify">inferiority of bisoprolol-first versus enalapril-first treatment was not proven in the per-protocol analysis, although the two strategies for initiation of CHF treatment showed a similar rate of the primary combined end point death and hospitalization at study end (32.4% in the bisoprolol-first group vs. 33.1% in the enalapril-first group, per-protocol population). The study shows that Bisoprolol Fumarate can also be used in elderly chronic heart failure patients with mild to moderate disease.</p><p style="text-align:justify">Bisoprolol fumarate is already used for the treatment of hypertension and angina.</p><p style="text-align:justify">In acute administration in patients with coronary heart disease without chronic heart failure bisoprolol fumarate reduces the heart rate and stroke volume and thus the cardiac output and oxygen consumption. In chronic administration the initially elevated peripheral resistance decreases.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:justify"><u>Absorption</u></p><p style="text-align:justify">Bisoprolol fumarate is absorbed and has a biological availability of about 90% after oral administration.</p><p style="text-align:justify"><u>Distribution</u></p><p style="text-align:justify">The distribution volume is 3.5 l/kg. The plasma protein binding of bisoprolol fumarate is about 30%.</p><p style="text-align:justify"><u>Biotransformation and Elimination</u></p><p style="text-align:justify">Bisoprolol fumarate is excreted from the body by two routes. 50% is metabolised by the liver to inactive metabolites which are then excreted by the kidneys. The remaining 50% is excreted by the kidneys in an unmetabolised form. Total clearance is approximately 15 l/h. The half-life in plasma of 10-12 hours gives a 24 hour effect after dosing once daily.</p><p style="text-align:justify"><u>Linearity</u></p><p style="text-align:justify">The kinetics of bisoprolol fumarate are linear and independent of age. <u>Special populations</u></p><p style="text-align:justify">Since the elimination takes place in the kidneys and the liver to the same extent a dosage adjustment is not required for patients with impaired liver function or renal insufficiency. The pharmacokinetics in patients with stable chronic heart failure and with impaired liver or renal function has not been studied. Patients with chronic heart failure (NYHA stage III) the plasma levels of bisoprolol are higher and the half-life is prolonged compared to healthy volunteers. Maximum plasma concentration at steady state is 64<u>+</u>21 ng/ml at a daily dose of 10 mg and the half-life is 17<u>+</u>5 hours.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:justify">Preclinical data reveal no special hazard for humans based on conventional studies of safety pharmacology, repeated dose toxicity, genotoxicity or carcinogenicity. Like other beta-blockers, bisoprolol fumarate caused maternal (decreased food intake and decreased body weight) and embryo/fetal toxicity (increased incidence of resorptions, reduced birth weight of the offspring, retarded physical development) at high doses but was not teratogenic.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Microcrystalline, Cellulose, Silica colloidal anhydrous, Croscarmellose sodium, Sodium Starch glycolate (Type A), Magnesium Stearate</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                3 years
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not store above 30&deg;C</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The container is a blister of white PVC/PVDC 250 / 60 sealed with 20 um Aluminium foil.</p><p>Pack size available: Carton of 30 Tab</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                AJA Pharmaceutical Industries Company, Ltd. 
Hail Industrial City MODON, Street No 32 
PO Box 6979, Hail 55414 
Kingdom of Saudi Arabia
Tel: +966 11 268 7900
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                October 2016
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>